THE EFFECT OF CIMETIDINE ON THE SINGLE DOSE PHARMACOKINETICS OF ORAL CLOBAZAM AND N-DESMETHYLCLOBAZAM

被引:14
|
作者
PULLAR, T
EDWARDS, D
HAIGH, JRM
PEAKER, S
FEELY, MP
机构
关键词
D O I
10.1111/j.1365-2125.1987.tb03051.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:317 / 321
页数:5
相关论文
共 50 条
  • [1] A COMPARISON OF THE SINGLE DOSE PHARMACOKINETICS OF N-DESMETHYLCLOBAZAM AND CLOBAZAM IN HEALTHY-VOLUNTEERS
    PULLAR, T
    HAIGH, JRM
    PEAKER, S
    FEELY, MP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (02) : P269 - P270
  • [2] Pharmacokinetics of N-Desmethylclobazam - Clobazam's Active and Primary Metabolite
    Tolbert, Dwain
    Bekersky, Ihor
    ANNALS OF NEUROLOGY, 2013, 74 : S72 - S72
  • [3] Pharmacokinetics of N-Desmethylclobazam, the Active and Primary Metabolite of Clobazam
    Tolbert, Dwain
    Bekersky, Ihor
    NEUROLOGY, 2013, 80
  • [4] BRAIN CONCENTRATIONS OF CLOBAZAM AND N-DESMETHYLCLOBAZAM AND ANTILEPTAZOL ACTIVITY
    CACCIA, S
    GUISO, G
    GARATTINI, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (04) : 295 - 296
  • [5] N-DESMETHYLCLOBAZAM - A POSSIBLE ALTERNATIVE TO CLOBAZAM IN THE TREATMENT OF REFRACTORY EPILEPSY
    HAIGH, JRM
    PULLAR, T
    GENT, JP
    DAILLEY, C
    FEELY, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (02) : 213 - 218
  • [6] Pharmacokinetics of Clobazam and N-Desmethylclobazam in Children with Dravet Syndrome Receiving Concomitant Stiripentol and Valproic Acid
    Vincent Jullien
    Stéphanie Chhun
    Elisabeth Rey
    Olivier Dulac
    Michel Tod
    Catherine Chiron
    Gérard Pons
    Clinical Pharmacokinetics, 2015, 54 : 527 - 536
  • [7] SERUM AND CEREBROSPINAL-FLUID CONCENTRATION OF CLOBAZAM AND N-DESMETHYLCLOBAZAM
    LAUX, G
    KOEPPEN, D
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1984, 22 (07) : 355 - 359
  • [8] Pharmacokinetics of Clobazam and N-Desmethylclobazam in Children with Dravet Syndrome Receiving Concomitant Stiripentol and Valproic Acid
    Jullien, Vincent
    Chhun, Stephanie
    Rey, Elisabeth
    Dulac, Olivier
    Tod, Michel
    Chiron, Catherine
    Pons, Gerard
    CLINICAL PHARMACOKINETICS, 2015, 54 (05) : 527 - 536
  • [9] Importance of Monitoring Clobazam and N-Desmethylclobazam Levels in Treatment with Cannabidiol (CBD) for Epilepsy
    Gaston, Tyler
    Bebin, E.
    Szaflarski, Jerzy
    NEUROLOGY, 2016, 86
  • [10] QUANTITATIVE-DETERMINATION OF CLOBAZAM AND N-DESMETHYLCLOBAZAM BY HPLC - APPLICATION TO A PHARMACOKINETIC STUDY
    BIEHLER, J
    PUIG, P
    POEY, J
    BOURBON, P
    THERAPIE, 1985, 40 (03): : 167 - 171